• About us
• Contact

Advertisement

Organisation › Details

EQT AB

EQT is a leading alternative investments firm with approximately EUR 37 billion in raised capital across 24 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. EQT is an active investor and owner in the healthcare sector, including recent investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima Corporate. *

 

	Start	1994-01-01 established
	Group	EQT (Wallenberg family) (Group)
	Predecessor	Investor AB
	Industry	private equity
	Region	Stockholm
	Country	Sweden
	Street	3 Hovslagargatan
	City	11148 Stockholm
	Tel	+46-8-506-55300
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	41,000,000,000 (assets, managed (2021) 2021-05-31)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for EQT (Wallenberg family) (Group)

• [1] Aerska. (2/9/26). "Press Release: Aerska Raises $39M Series A Financing Led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain". Dublin & London....
• [2] FoRx Therapeutics AG. (12/18/25). "Press Release: FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor". Basel....
• [3] EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million"....
• [4] Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve....
• [5] Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich....
• [6] Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto....
• [7] VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam....
• [8] EQT AB. (6/21/23). "Press Release: EQT Private Equity to Sell Ellab, Following Transformation into a Leading Validation & Monitoring Provider for the Biotech and Pharmaceutical Industries"....
• [9] EQT AB. (3/29/23). "Press Release: EQT Life Sciences Closes Dementia Fund at the Hard Cap"....
• [10] va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.